Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

METORTRIT™ injection solution 10mg/ml (1.5ml), syringes 1pc

🔥 6 items sold in last 3 hours
20 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$74.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

METORTRIT™ injection solution 10mg/ml (0.75ml), syringe 1pc

$54.00
Add to cart

METORTRIT™ injection solution 10mg/ml (1ml), syringe 1pc

$64.00
Add to cart

Analogs of METORTRIT™

METOJECT™ solution for subcutaneous injection 50mg/ml (0.25ml), syringes 1pc

$50.00
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.35ml), syringes 1pc

$73.00
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.4ml), syringes 1pc

$70.00
Add to cart

METOJECT™ solution for subcutaneous injection 50mg/ml (0.5ml), syringes 1pc

$86.00
Add to cart

Table of Contents

METORTRIT™ 10mg Solution 1.5ml Buy Online

Understanding METORTRIT Injection Solution

METORTRIT injection solution is a potent medication with significant implications in the treatment of various conditions. Its mechanism of action, as an antineoplastic and immunosuppressant, makes it a valuable tool in the hands of experienced medical professionals. This injectable solution, containing methotrexate, offers a targeted approach to managing specific health challenges.

Understanding the intricacies of this medication is crucial for both patients and healthcare providers. Its precise applications, potential side effects, and administration methods all require careful consideration. This detailed overview will illuminate the key aspects of METORTRIT injection solution and its role in modern medicine.

This article aims to provide a comprehensive understanding of METORTRIT, empowering informed decision-making in the context of patient care. Remember, this information is for educational purposes only and should not substitute professional medical advice. Always consult with a healthcare professional before starting any new medication.

A Powerful Anti-cancer and Immunosuppressant

METORTRIT injection solution, containing methotrexate, demonstrates a dual-action profile as a potent anticancer and immunosuppressant agent. Its efficacy stems from its ability to interfere with crucial cellular processes, impacting both rapidly dividing cancer cells and the body’s immune response.

As an antineoplastic agent, methotrexate disrupts the synthesis of DNA and RNA, essential for cell replication. This targeted disruption leads to cell death, particularly affecting cancerous cells that proliferate rapidly. The mechanism involves the inhibition of dihydrofolate reductase, a key enzyme in nucleotide synthesis.

Simultaneously, METORTRIT exhibits immunosuppressive properties. By modulating the immune system’s activity, it can effectively reduce inflammation and the associated symptoms of autoimmune diseases. This dual action makes it a versatile tool in managing a range of conditions where both cancer cell proliferation and immune dysregulation play significant roles. However, this powerful dual action necessitates careful monitoring and administration under strict medical supervision.

The precise effects and potency of METORTRIT’s anti-cancer and immunosuppressive actions depend on various factors, including dosage, route of administration, and the individual patient’s response. It is crucial to understand that this medication is not a standalone solution and should be part of a comprehensive treatment plan designed by a healthcare professional.

The multifaceted nature of METORTRIT’s action highlights its complexity and the need for careful consideration of its potential benefits and risks in specific clinical contexts. Its use requires a thorough understanding of its pharmacological properties and potential side effects to ensure optimal therapeutic outcomes and minimize adverse events.

Mechanism of Action

METORTRIT’s primary active component, methotrexate, exerts its therapeutic effects through a sophisticated mechanism targeting cellular processes crucial for growth and replication. It acts as a folate antagonist, competitively inhibiting dihydrofolate reductase (DHFR).

This enzyme is vital for the synthesis of purines and pyrimidines, the building blocks of DNA and RNA. By blocking DHFR, methotrexate effectively halts the production of these essential molecules, thereby inhibiting cell division and ultimately leading to cell death. This effect is particularly pronounced in rapidly dividing cells, such as cancer cells.

The impact on rapidly proliferating cells explains METORTRIT’s efficacy in cancer treatment. However, the inhibition of DHFR also affects other rapidly dividing cells, including those of the immune system. This explains its immunosuppressive action, useful in managing autoimmune diseases where immune system overactivity contributes to pathology.

Beyond its direct effects on DNA synthesis, methotrexate also influences other metabolic pathways, contributing to its multifaceted therapeutic actions. These secondary effects enhance its anti-inflammatory and immunomodulatory properties, further broadening its clinical utility. The precise effects vary based on dosage and individual patient factors.

Understanding METORTRIT’s intricate mechanism of action is crucial for appreciating both its therapeutic potential and the potential for side effects. The inhibition of rapidly dividing cells, while beneficial in treating cancer and autoimmune disorders, can also impact healthy cells, necessitating careful monitoring and management of potential adverse reactions. Its precise effects are complex and depend on multiple interacting factors.

Therapeutic Applications

METORTRIT injection solution finds its primary therapeutic applications in the management of specific cancers and autoimmune disorders. Its multifaceted mechanism of action, combining anti-cancer and immunosuppressant properties, makes it a valuable tool in various clinical settings. The specific conditions treated and the dosage regimen vary significantly depending on the individual patient and their specific needs.

In oncology, METORTRIT may be used in the treatment of certain types of cancers, often as part of a combination therapy. The specific cancers for which it is indicated are determined by the treating oncologist and depend on various factors, including the type and stage of the cancer. It’s crucial to remember that METORTRIT’s use in cancer treatment is highly specialized and requires expert medical oversight.

Furthermore, METORTRIT plays a crucial role in the management of several autoimmune diseases. Its immunosuppressive properties help control the overactive immune response that characterizes these conditions. Specific autoimmune conditions where METORTRIT might be used include rheumatoid arthritis, psoriatic arthritis, and other inflammatory disorders. Dosage and administration protocols are tailored to each patient’s unique condition and response to treatment.

The application of METORTRIT extends to other inflammatory conditions beyond autoimmune diseases. Its ability to modulate immune responses makes it a potential therapeutic option in selected cases. However, the use of METORTRIT in these less common applications should be guided by a thorough risk-benefit assessment performed by a qualified healthcare professional familiar with its complex pharmacological profile.

It is important to reiterate that the use of METORTRIT is strictly under the guidance of a physician experienced in its administration and capable of managing potential side effects. The choice of therapeutic application and the specific treatment regimen depend on a comprehensive evaluation of the patient’s medical history, condition, and overall health status. Treatment plans are highly individualized.

Administration and Dosage

The administration and dosage of METORTRIT injection solution are strictly determined by a healthcare professional based on the individual patient’s condition, medical history, and response to treatment. It is crucial to emphasize that self-administration is never recommended. The medication should only be administered by trained medical personnel.

METORTRIT can be administered via various routes, including subcutaneous, intramuscular, or intravenous injection. The chosen route depends on several factors, including the specific indication, patient tolerance, and the overall treatment plan. The physician will select the optimal route based on these considerations, ensuring patient safety and efficacy.

Dosage is carefully titrated to achieve the desired therapeutic effect while minimizing adverse events. Initial dosages are typically low and gradually increased as tolerated, under close medical supervision. Regular monitoring of blood counts and other relevant laboratory parameters is essential to assess the patient’s response and adjust the dosage accordingly. Frequent adjustments might be necessary.

The frequency of administration also varies widely depending on the clinical context. It can range from weekly injections to less frequent administrations, depending on the therapeutic goals and the individual patient’s response. Treatment plans are highly personalized, reflecting the complexity of this medication’s use.

Precise dosage and administration guidelines are not provided here, as these details are highly individualized and should always be determined and supervised by a qualified healthcare professional. Improper administration or dosage can lead to serious adverse effects. The physician’s expertise ensures safe and effective treatment.

Potential Side Effects

While METORTRIT can be highly effective, it’s crucial to be aware of the potential side effects. These can range from mild to severe, and their occurrence and severity vary significantly depending on the individual patient, dosage, and duration of treatment. Close monitoring by a healthcare professional is essential to detect and manage any adverse reactions promptly.

Common side effects may include nausea, vomiting, diarrhea, mouth sores, fatigue, and hair loss. These are often manageable and may subside as the body adjusts to the medication. However, more severe side effects are possible and require immediate medical attention. Patients should report any unusual symptoms to their doctor immediately.

Serious side effects, though less common, can include bone marrow suppression (leading to decreased blood cell counts), liver damage, kidney problems, and serious lung infections. These necessitate careful monitoring of blood work and other relevant laboratory parameters throughout the treatment course. Early detection is crucial for effective intervention.

Infections are a significant concern, given METORTRIT’s immunosuppressive properties. Patients should practice meticulous hygiene and report any signs of infection promptly. The risk of infection is heightened during treatment, and prophylactic measures may be necessary to mitigate this risk. Close communication with a healthcare provider is paramount.

The potential for serious adverse events highlights the importance of careful patient selection and ongoing medical supervision. Only patients who meet specific criteria and are closely monitored should receive METORTRIT. The risks and benefits should be carefully weighed before initiating treatment, and regular assessments are essential to ensure patient safety and efficacy.

Pros

METORTRIT injection solution offers several key advantages in specific clinical contexts. Its effectiveness in managing certain cancers and autoimmune diseases is a significant benefit, providing relief from debilitating symptoms and potentially improving long-term outcomes. However, it is crucial to remember that these benefits must be carefully weighed against potential risks.

The targeted mechanism of action, focusing on rapidly dividing cells, allows for a degree of selectivity, minimizing the impact on healthy cells compared to some broader-spectrum therapies. This targeted approach can contribute to a more favorable side effect profile, although it is important to note that side effects still occur and require careful management.

For certain conditions, METORTRIT may provide superior efficacy compared to alternative treatments. In some cases, it may be the only effective treatment option available. This makes it a valuable tool for healthcare professionals seeking to optimize patient care for difficult-to-treat conditions. However, the decision to use METORTRIT is always individualized.

The injectable formulation allows for precise dosage control and rapid onset of action, leading to quicker symptom relief in some instances. This rapid effect can be particularly beneficial in acute situations where prompt intervention is crucial. This advantage contrasts with some treatments that have a more delayed onset of effect.

Finally, the availability of METORTRIT as a pre-filled syringe simplifies administration, potentially reducing the risk of errors associated with manual medication preparation. This streamlined process can contribute to improved patient convenience and enhance the overall efficiency of treatment delivery. This aspect is important for both patients and healthcare providers.

Cons

Despite its therapeutic benefits, METORTRIT carries potential drawbacks that must be carefully considered. The risk of significant side effects, ranging from mild discomfort to severe complications, is a major concern. These side effects can impact various organ systems and necessitate close medical monitoring throughout the treatment course.

The need for frequent blood tests and other laboratory monitoring adds to the burden of treatment. This regular monitoring is essential for early detection of adverse effects and timely intervention, but it can be inconvenient and add to the overall cost and complexity of care. Close follow-up is critical for patient safety.

METORTRIT’s immunosuppressive properties increase susceptibility to infections, a significant risk for patients already compromised by their underlying condition. This heightened risk necessitates proactive measures to prevent infections, including careful hygiene practices and potential prophylactic antibiotics. Infection prevention is a crucial aspect of management.

The potential for long-term organ damage, particularly to the liver and kidneys, is a serious consideration. Regular monitoring of organ function is crucial to minimize the risk of irreversible damage. Early detection of organ dysfunction allows for timely intervention and may prevent or mitigate long-term consequences.

Finally, the high cost of treatment, coupled with the need for frequent medical visits and monitoring, can present significant financial and logistical challenges for some patients. Access to care and affordability are important factors that should be addressed in the context of treatment planning. Careful consideration of the overall treatment burden is essential.

Conclusion

METORTRIT injection solution represents a powerful therapeutic option for specific cancers and autoimmune diseases, offering significant benefits for appropriately selected patients. However, its use necessitates careful consideration of potential risks and requires close medical supervision. The complex pharmacological profile demands a thorough understanding of its mechanism of action and potential side effects.

The decision to utilize METORTRIT should always be made in consultation with a healthcare professional experienced in its administration and capable of managing potential complications. A comprehensive risk-benefit assessment is crucial, considering the individual patient’s medical history, overall health, and the severity of their condition. Patient safety is paramount.

While METORTRIT offers the potential for significant therapeutic gains, the associated risks must be carefully weighed. The need for frequent monitoring, the potential for serious side effects, and the high cost of treatment all contribute to the complexity of managing this medication. Close collaboration between patient and physician is essential for optimal outcomes.

This information should not be interpreted as a substitute for professional medical advice. Always consult with a qualified healthcare provider before making any decisions related to your health or treatment. They can provide personalized guidance based on your individual needs and circumstances. Informed decision-making is key to successful treatment.

Ultimately, the success of METORTRIT therapy hinges on a collaborative approach involving the patient, physician, and other members of the healthcare team. Open communication, adherence to the prescribed treatment regimen, and meticulous monitoring are vital for maximizing therapeutic benefits and minimizing potential harm. Patient engagement is crucial for positive outcomes.

  • Metortrit™ Injection Solution 10Mg/Ml (1.5Ml), Syringes 1Pc Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Metortrit™ Injection Solution 10Mg/Ml (1.5Ml), Syringes 1Pc Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Metortrit™ Injection Solution 10Mg/Ml (1.5Ml), Syringes 1Pc Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “METORTRIT™ injection solution 10mg/ml (1.5ml), syringes 1pc”

Your email address will not be published. Required fields are marked

Similar products

LESTRODEX™ tablets 2.5mg, 30pcs

$134.00
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (15ml), vial 1pc

$80.00
Add to cart

CARBOPLATIN-RONC™ concentrate for infusion solution 10mg/ml (45ml), vial 1pc

$158.00
Add to cart

CAPECITABINE tablets 500mg, 120pcs

$530.00
Add to cart

CABOMETYX™ tablets 40mg, 30pcs

$25,072.00
Add to cart

CABOMETYX™ tablets 60mg, 30pcs

$25,072.00
Add to cart

IRINOTECAN-TEVA™ concentrate for infusion solution 20mg/ml (2ml), vial 1pc

$100.00
Add to cart

IRITEN™ concentrate for infusion solution 20mg/ml (5ml), vial 1pc

$195.00
Add to cart

IMBRUVICA™ capsules 140mg, 90pcs

$28,002.00
Add to cart

ZOLADEX™ implant 10.8mg, syringe applicators 1pc

$854.00
Add to cart

ZOLADEX™ implant 3.6mg, syringe applicators 1pc

$253.00
Add to cart

ZENLISTIK™ tablets 150mg, 56pcs

$4,810.00
Add to cart

DOCETAXEL SANDOZ™ concentrate for infusion solution 10mg/ml (8ml), vial 1pc

$689.00
Add to cart

DOXORUBICIN lyophilisate for intravascular and intravesical solution 10mg, 1pc

$19.00
Add to cart

HYDREA™ capsules 500mg, 20pcs

$16.00
Add to cart

HEMANGIOL™ oral solution 3.75mg/ml (120ml), vial 1pc

$1,143.00
Add to cart

BLINCYTO™ powder for concentrate for infusion solution 35mcg+stabilizer, vial 1pc

$11,337.00
Add to cart

BLINCYTO™ lyophilisate for concentrate for infusion solution 35mcg+stabilizer, vial 1pc

$11,119.00
Add to cart

BICALUTAMIDE CANON™ tablets 150mg, 30pcs

$108.00
Add to cart

BICALUTAMIDE tablets 50mg, 30pcs

$77.00
Add to cart

BIKANA™ tablets 50mg, 28pcs

$53.00
Add to cart

ARFLEIDA™ concentrate for infusion solution 25mg/ml (4ml), 1 vial

$7,437.00
Add to cart

ANASTROZOLE tablets 1mg, 30pcs

$80.00
Add to cart

AVASTIN™ concentrate for infusion solution 25mg/ml (400mg/16ml), vial 16ml 1pc

$2,272.00
Add to cart
Select your currency